VenatoRx Pharmaceuticals
-
Malvern-Based Venatorx Pharmaceuticals Scales Down of Operations
As it winds down operations, antibiotics developer Venatorx Pharmaceuticals is auctioning off equipment from its Malvern-based research facility, writes John George for the Philadelphia Business Journal. The Chester County company, which…
-
After ‘Challenging but Rewarding Journey’, CEO of Malvern’s Venatorx Pharmaceuticals Steps Down
Christopher Burns, a co-founder of Malvern-based Venatorx Pharmaceuticals, is stepping down from his position as the company’s CEO, writes John George for the Philadelphia Business…
-
Malvern-Based Venatorx Pharmaceuticals Expects Big News About Its Lead Antibiotic Candidate
Venatorx Pharmaceuticals, a Malvern life sciences company, expects to hear from the Food and Drug Administration regarding its new drug application for its lead antibiotic…
-
Malvern Pharmaceutical Company Lands Federal Contract to Support National Preparedness Efforts
Malvern-based Venatorx Pharmaceuticals was awarded a federal BioShield contract by the Biomedical Advanced Research and Development Authority that could net the antibiotics company up to…
-
Malvern-Based Pharmaceutical Company Set to Tackle One of the World Health Organization’s Top Priorities
Malvern-based VenatoRx Pharmaceuticals has teamed with a Swiss pharmaceutical company to work on a new class of antibiotics that would address the growing threat of…
-
Chester County Home to Eight of the Region’s Fastest-Growing Companies
The 2021 “Soaring 76” — local companies that the Philadelphia Business Journal reports are booming — includes eight from Chester County, writes Sharon Oliver for…
-
Next Wave of Antibiotics Being Developed in a Malvern Lab
Malvern-based VenatoRx Pharmaceuticals is working hard to develop the next wave of antibiotics to fight hard-to-treat bacterial and viral infections, writes Queen Muse for Philadelphia…
-
Pharma Firm in Malvern Optimistic as Policymakers Rethink How Drug Manufacturers Are Paid
Outdated reimbursement policies are causing many developers of novel antibiotics that treat drug-resistant superbugs to declare bankruptcy, but Malvern-based VenatoRx Pharmaceuticals believes it can buck…
-
Malvern-Based Antibiotics Developer Awarded $4.1 Million for Research Targeting Drug-Resistant STD
A global nonprofit partnership has awarded Malvern-based VenatoRx Pharmaceuticals $4.1 million to develop a treatment for a drug-resistant STD, writes John George for the Philadelphia…
-
Chester County Briefly: August 22
Chester County Women’s Services Coatesville-based CCWS, a nonprofit pregnancy care medical center, is holding its annual 5K Run/Walk for Life on Saturday, Sept. 16 at…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
